Correlation Between Innovation Beverage and Microbot Medical

Can any of the company-specific risk be diversified away by investing in both Innovation Beverage and Microbot Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innovation Beverage and Microbot Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Innovation Beverage Group and Microbot Medical, you can compare the effects of market volatilities on Innovation Beverage and Microbot Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innovation Beverage with a short position of Microbot Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innovation Beverage and Microbot Medical.

Diversification Opportunities for Innovation Beverage and Microbot Medical

0.13

Correlation Coefficient

Innovation Beverage  Microbot Medical

Average diversification

The 3 months correlation between Innovation and Microbot is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Innovation Beverage Group and Microbot Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Microbot Medical and Innovation Beverage is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innovation Beverage Group are associated (or correlated) with Microbot Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Microbot Medical has no effect on the direction of Innovation Beverage i.e., Innovation Beverage and Microbot Medical go up and down completely randomly.

Pair Corralation between Innovation Beverage and Microbot Medical

Considering the 90-day investment horizon Innovation Beverage Group is expected to under-perform the Microbot Medical. But the stock apears to be less risky and, when comparing its historical volatility, Innovation Beverage Group is 2.09 times less risky than Microbot Medical. The stock trades about -0.16 of its potential returns per unit of risk. The Microbot Medical is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  118.00  in Microbot Medical on December 30, 2024 and sell it today you would earn a total of  28.00  from holding Microbot Medical or generate 23.73% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Innovation Beverage Group  vs.  Microbot Medical

Innovation Beverage

Risk-Adjusted Performance

Very Weak

Over the last 90 days Innovation Beverage Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental drivers remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Microbot Medical

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Microbot Medical are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Microbot Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Innovation Beverage and Microbot Medical

The main advantage of trading using opposite Innovation Beverage and Microbot Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innovation Beverage position performs unexpectedly, Microbot Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbot Medical will offset losses from the drop in Microbot Medical's long position.

The idea behind Innovation Beverage Group and Microbot Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.